PL409595A1 - Sposób otrzymywania pseudofaktyny - Google Patents
Sposób otrzymywania pseudofaktynyInfo
- Publication number
- PL409595A1 PL409595A1 PL409595A PL40959514A PL409595A1 PL 409595 A1 PL409595 A1 PL 409595A1 PL 409595 A PL409595 A PL 409595A PL 40959514 A PL40959514 A PL 40959514A PL 409595 A1 PL409595 A1 PL 409595A1
- Authority
- PL
- Poland
- Prior art keywords
- leu
- peptide
- tbu
- side chain
- pseudofactin
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-Leucine Natural products CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001718 carbodiimides Chemical class 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
- 238000001308 synthesis method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Przedmiotem wynalazku jest sposób syntezy pseudofaktyny charakteryzujący się tym, że obejmuje etapy: syntezy w fazie stałej peptydu Palm-Gly-Ser(tBu)-Thr-Leu-Leu-Ser(tBu)-Leu-Leu-OH metodą karbodiimidową, odszczepienie peptydu z żywicy z zachowaniem osłony tBu na łańcuchu bocznym L-seryny, cyklizację wewnętrzną peptydu polegającą na tworzeniu wiązania estrowego pomiędzy grupą hydroksylową łańcucha bocznego L-treoniny a grupą karboksylową L-leucyny, usunięcie osłon znajdujących się w łańcuchu bocznym L-seryny oraz oczyszczanie otrzymanego peptydu.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL409595A PL409595A1 (pl) | 2014-09-25 | 2014-09-25 | Sposób otrzymywania pseudofaktyny |
| EP15020002.0A EP3000822B1 (en) | 2014-09-25 | 2015-01-08 | A novel method of pseudofactin synthesis |
| PL15020002T PL3000822T3 (pl) | 2014-09-25 | 2015-01-08 | Nowy sposób syntezy pseudofaktyny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL409595A PL409595A1 (pl) | 2014-09-25 | 2014-09-25 | Sposób otrzymywania pseudofaktyny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL409595A1 true PL409595A1 (pl) | 2016-03-29 |
Family
ID=52358604
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL409595A PL409595A1 (pl) | 2014-09-25 | 2014-09-25 | Sposób otrzymywania pseudofaktyny |
| PL15020002T PL3000822T3 (pl) | 2014-09-25 | 2015-01-08 | Nowy sposób syntezy pseudofaktyny |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15020002T PL3000822T3 (pl) | 2014-09-25 | 2015-01-08 | Nowy sposób syntezy pseudofaktyny |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3000822B1 (pl) |
| PL (2) | PL409595A1 (pl) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008058A (en) * | 1993-06-18 | 1999-12-28 | University Of Louisville | Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis |
-
2014
- 2014-09-25 PL PL409595A patent/PL409595A1/pl unknown
-
2015
- 2015-01-08 PL PL15020002T patent/PL3000822T3/pl unknown
- 2015-01-08 EP EP15020002.0A patent/EP3000822B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| EP3000822B1 (en) | 2018-10-31 |
| EP3000822A1 (en) | 2016-03-30 |
| PL3000822T3 (pl) | 2019-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123247T1 (el) | Διεργασια για το χειρισμο του επιπεδου της περιεκτικοτητας σε γλυκανη μιας γλυκοπρωτεϊνης | |
| AU2019268150A1 (en) | Isotyping immunoglobulins using accurate molecular mass | |
| EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
| EA201790984A1 (ru) | Анти-cd79b антитела и способы их применения | |
| PL3658495T3 (pl) | Sposób wytwarzania gazu syntezowego | |
| WO2014165082A3 (en) | Antibodies and methods of detection | |
| MX2015012428A (es) | Tratamiento contra enfermedades mediadas th2 por inhibicion de bromodominios. | |
| EP3705494A3 (en) | Antibodies against frizzled proteins and methods of use thereof | |
| ZA201703510B (en) | Antibodies, uses & methods | |
| MX385473B (es) | Sintesis comercialmente viable de cantaridina y derivados bioactivos de cantaridina. | |
| NZ730186A (en) | Humanized anti-hepcidin antibodies and uses thereof | |
| EP3693377A4 (en) | METHOD FOR PREPARING A PEPTIDE COMPOUND | |
| WO2014145897A3 (en) | Immunotherapy system and method thereof | |
| DK3354737T3 (da) | System til cellefri proteinsyntese | |
| EA201400939A1 (ru) | Способ получения медетомидина с использованием хлорацетона | |
| EA201400940A1 (ru) | Способ получения медетомидина | |
| IL277838A (en) | A method for separating a solid-phase bound peptide from the solid phase | |
| CL2018002689A1 (es) | Metodo para purificacion de proteinas | |
| IL291343A (en) | Immunotherapy compounds and methods | |
| EP2998743A3 (en) | Detection of indazole synthetic cannabinoids | |
| MX2019004116A (es) | Metodo de preparacion de peptidos que comprenden una cadena lateral de lisina modificada lipofilicamente. | |
| CL2020001182A1 (es) | Método para la síntesis de depsipéptidos cíclicos | |
| IL284816A (en) | Methods for improved immunotherapy | |
| PL409595A1 (pl) | Sposób otrzymywania pseudofaktyny | |
| SG11201707308XA (en) | Method for obtaining peptide fragment from antibody by protease decomposition reaction with restrictedreaction field |